Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia
| Image |  |
|---|---|
| Description | scientific article published on 17 April 2019 |
| Author/s |
author: Stephan Stilgenbauer Andrew D Zelenetz Bruce D. Cheson Paolo Ghia |
| Publication date | April 17, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |